Results 41 to 50 of about 3,398 (179)

Safety and efficacy of ferric carboxymaltose in anaemic antenatal women: a prospective study

, 2021
Background: Anemia is one of the most common nutritional deficiency disorders affecting the pregnant women, and is a worldwide problem. In India, prevalence ranges from 23.6%-61.4% and contributes to 80% of maternal mortality as a direct or indirect ...
Jamkhandi, Supriya, Tile, Rajesh
core   +1 more source

Novel approaches for drug development against chronic primary pain: A systematic review

British Journal of Pharmacology, EarlyView.
Abstract Chronic primary pain (CPP) persisting for more than 3 months, associated with significant emotional distress without any known underlying cause, is an unmet medical need. Traditional or adjuvant analgesics do not provide satisfactory pain relief for a great proportion of these patients.
Valéria Tékus, Éva Borbély, Andreas Goebel, Ralf Baron, Zsófia Hajna, Zsuzsanna Helyes   +5 more
wiley   +1 more source

Ferric carboxymaltose in patients with restless legs syndrome and nonanemic iron deficiency: A randomized trial.

, 2017
Background: Compromised iron status is important in restless legs syndrome pathophysiology. We compared the efficacy and tolerability of ferric carboxymaltose (single intravenous dose) versus placebo for restless legs syndrome treatment in iron-deficient
Roubert, B., Mezzacasa, A., Trenkwalder, C., Winkelmann, J., Oertel, W.H., Virgin, G.   +5 more
core   +2 more sources

Applying reflective multicriteria decision analysis to understand the value of therapeutic alternatives in the management of gestational and peripartum anaemia in Spain

BMC Pregnancy and Childbirth, 2022
Background The objective of the FeminFER project was to assess the value of ferric carboxymaltose following a multicriteria decision analysis in obstetrics and gynaecology in Spain.
Manel Casellas Caro, María Jesús Cancelo Hidalgo, José Antonio García-Erce, José Luis Baquero Úbeda, Maria Glòria Torras Boatella, Elena Gredilla Díaz, Margarita Ruano Encinar, Israel Martín Bayón, Jordi Nicolás Picó, José Eduardo Arjona Berral, Alberto Muñoz Solano, Silvia Jiménez Merino, Mónica Cerezales, Jesús Cuervo   +13 more
doaj   +1 more source

A comprehensive review of cancer‐induced cardiac wasting

British Journal of Pharmacology, EarlyView.
Cancer is frequently accompanied by cachexia, a systemic syndrome characterized by progressive loss of skeletal muscle mass, with or without loss of fat mass. Increasing evidence indicates that cancer can also induce cardiac muscle wasting, which is associated with structural cardiac remodelling, impaired contractile function and the development of ...
Alessia Lena, Muhammad Shahzeb Khan, Ulrich Keller, Lars Bullinger, Dominik P. Modest, Markus S. Anker   +5 more
wiley   +1 more source

Parenteral iron—Does it increase infection risk?

Vox Sanguinis, EarlyView.
Abstract Background and Objectives Iron deficiency (ID) and iron deficiency anaemia (IDA) are prevalent conditions impacting various patient populations, both surgical and non‐surgical conditions. The advent of patient blood management (PBM) has promoted intravenous (IV) iron therapy as an alternative to oral iron and blood transfusions.
Joyisa Deb, Aswin K. Mohan, Suhasini Sil, Suvro Sankha Datta, Yoghini Nagandran, Manideepa Maji, Mohammad Kamrul Hassan Majumder, Saikat Mandal   +7 more
wiley   +1 more source

Intravenous ferric carboxymaltose accelerates erythropoietic recovery from experimental malarial anemia

, 2012
Iron restriction has been proposed as a cause of erythropoietic suppression in malarial anemia; however, the role of iron in malaria remains controversial, because it may increase parasitemia.
Sharp, Rebecca Emilie, Andersson, Mikael, Kurtzhals, Jørgen A L, Maretty, Lasse   +3 more
core   +1 more source

Danger of co-administration ferric carboxymaltose and denosumab: hypophosphatemia

The Egyptian Journal of Internal Medicine
Both denosumab-induced hypocalcemia and ferric carboxymaltose infusion-related hypophosphatemia have been extensively documented. There are significant risks associated with combining ferric carboxymaltose parenteral infusions and denosumab, including ...
Aysun Seker, Nurdan Senturk Durmus
doaj   +1 more source

IV Sodium Ferric Gluconate Complex in Patients Hospitalized Due to Acute Decompensated Heart Failure and Iron Deficiency

Journal of Cardiovascular Pharmacology and Therapeutics, 2022
Background: Patients suffering from heart failure (HF) and iron deficiency (ID) have worse outcomes. Treatment with intra-venous (IV) ferric carboxymaltose has been shown to reduce HF rehospitalizations and to improve functional capacity and symptoms in ...
Itay Borreda MD, Robert Zukermann MD, Danny Epstein MD, Erez Marcusohn MD   +3 more
doaj   +1 more source

Rationale and Design of the Türkiye Heart Failure (TURK‐HF) Registry

Clinical Cardiology, Volume 49, Issue 5, May 2026.
ABSTRACT Aims The Türkiye Heart Failure (TURK‐HF) registry aims to identify the sociodemographic and clinical characteristics, management strategies, and outcomes of patients with heart failure (HF) and to assess the implementation of evidence‐based HF therapies in Türkiye.
Umut Kocabas, Selda Murat, Tarık Kıvrak, Bektaş Murat, Cihan Altın, Cennet Yıldız, Şeyda Günay Polatkan, Selma Akdeniz Oskay, Zeynep Ulutaş, Duygu İnan, Nuran Günay, Dilay Karabulut, Fahri Çakan, Veysel Yavuz, Isil Ergin, Uğur Önsel Türk, İstemihan Tengiz, The TURK‐HF Registry Investigators, Veysel Ozan Tanık, Türkan Seda Tan Kürklü, Ali Nail Kaya, Mevlüt Demir, Taner Şen, Çağatay Tunca, Gülsüm Meral Yılmaz Öztekin, Meltem Altınsoy, Ümit Yaşar Sinan, Cengiz Şabanoğlu, Mehmet Kaplan, Emre Özçalık, Işık Tekin, Oğuzhan Birdal, Mustafa Doğduş, Anıl Şahin, Örsan Deniz Urgun, Emin Erdem Kaya, Fulya Avcı Demir, Mustafa Yenerçağ, Abdullah Tunçez, Umut Karabulut, Halil İbrahim Tanrıseven, İbrahim Halil Özdemir, Melih Öz, Cemre Turgul, Atakan Şengöz, Nurullah Çetin, Fahri Er   +46 more
wiley   +1 more source